The object of the IASON project is the development of a system which is characterized by combining
- Diagnosing Alzheimer's disease at a (preclinical) stage of its development, when no symptoms are yet manifest,
- Supporting Alzheimer's patients with an “Intelligent Emotionally Empathic Digital Assistant (IEEDA)” in their practical everyday life, see the corresponding article on iason.ai,
- and supporting the therapy of Alzheimer's patients by a novel approach, gamma entrainment, the effectiveness of which has been demonstrated in a mouse model by scientists from the Picower Institute and the Singer Lab,
For further information, see www.iason.ai.